Cipla jumps nearly 5% after USFDA nod for generic Ventolin inhaler
Cipla jumps nearly 5% after USFDA nod for generic Ventolin inhaler
Cipla jumps nearly 5% after USFDA nod for generic Ventolin inhaler
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
POSITIVE
Published
09 May 2026
📎 Sources
CNBC TV18 | https://www.tradingview.com/news/cnbctv:af957549b094b:0/